KALAMAZOO, Mich., Dec. 4 /PRNewswire-FirstCall/ -- Stryker Corporation
(NYSE: SYK) announced today that it will participate in the following investor
conference:
December 7, 2006 - 10:30 a.m. Eastern Time
BMO Capital Markets Focus on Healthcare Conference
New York, New York
A simultaneous webcast of the Company's presentation will be available on
Stryker's website at http://www.stryker.com via the For Investors page. The
presentation for the BMO Capital Markets Focus on Healthcare Conference will
be archived for 30 days.
Certain statements made in the presentation may constitute forward-looking
statements. They will be based upon management's current expectations and
will be subject to various risks and uncertainties that could cause the
Company's actual results to differ materially from those expressed or implied
in such statements. In addition to factors that may be discussed in the
presentation, such factors include, but are not limited to: pricing pressures
generally, including cost-containment measures that could adversely affect the
price of or demand for the Company's products; regulatory actions;
unanticipated issues arising in connection with clinical studies and eventual
United States Food and Drug Administration approval of additional OP-1
applications, the FlexiCore and CerviCore spinal implant products, the
PlasmaSol sterilization products or other new product introductions;
integration and other issues that could delay the introduction of the recently
acquired Sightline product line; changes in reimbursement levels from third-
party payors; a significant increase in product liability claims; changes in
economic conditions that adversely affect the level of demand for the
Company's products; changes in foreign exchange markets; changes in financial
markets; and changes in the competitive environment. Additional information
concerning these and other factors are contained in the Company's filings with
the Securities and Exchange Commission, including the Company's Annual Report
on Form 10-K and Quarterly Reports on Form 10-Q.
Stryker Corporation is one of the world's leading medical technology
companies with the most broadly based range of products in orthopaedics and a
significant presence in other medical specialties. Stryker works with
respected medical professionals to help people lead more active and more
satisfying lives. The Company's products include implants used in joint
replacement, trauma, craniomaxillofacial and spinal surgeries; biologics;
surgical, neurologic, ear, nose & throat and interventional pain equipment;
endoscopic, surgical navigation, communications and digital imaging systems;
as well as patient handling and emergency medical equipment. Stryker also
provides outpatient physical therapy services in the United States.
SOURCE Stryker Corporation
CONTACT: Dean H. Bergy, Vice President and Chief Financial Officer of
Stryker Corporation, +1-269-385-2600
Web site: http://www.stryker.com
(SYK)